Advertisement
Screener

EPIRUS Biopharmaceuticals, Inc. Operating Income

EPIRUS Biopharmaceuticals, Inc. Operating Income

EPIRUS Biopharmaceuticals, Inc. reported Operating Income of -$16.01 million for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-10.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2016-05-10

  • EPIRUS Biopharmaceuticals, Inc. operating income (loss) for the quarter ending 2016-03-31 was -$16.01M.
  • EPIRUS Biopharmaceuticals, Inc. operating income (loss) for the quarter ending 2015-12-31 was -$16.03M.
  • EPIRUS Biopharmaceuticals, Inc. operating income (loss) for the quarter ending 2015-09-30 was -$14.04M.
  • EPIRUS Biopharmaceuticals, Inc. operating income (loss) for the quarter ending 2015-06-30 was -$15.01M.
  • EPIRUS Biopharmaceuticals, Inc. operating income (loss) for fiscal 2015 was -$52.30M.
  • EPIRUS Biopharmaceuticals, Inc. operating income (loss) for fiscal 2014 was -$39.26M.
  • EPIRUS Biopharmaceuticals, Inc. operating income (loss) for fiscal 2013 was -$14.47M.
  • EPIRUS Biopharmaceuticals, Inc. operating income (loss) for fiscal 2012 was -$42.84M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2016-03-31-$16.01M
10-Q · filed 2016-05-10
-$32.03M
derived: sum of 2 quarters · filed 2016-05-10
-$46.08M
derived: sum of 3 quarters · filed 2016-05-10
-$61.09M
derived: sum of 4 quarters · filed 2016-05-10
2015-12-31-$16.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
-$30.07M
derived: sum of 2 quarters · filed 2016-03-29
-$45.08M
derived: sum of 3 quarters · filed 2016-03-29
-$52.30M
10-K · filed 2016-03-29
2015-09-30-$14.04M
10-Q · filed 2015-11-16
-$29.05M
derived: sum of 2 quarters · filed 2015-11-16
-$36.27M
10-Q · filed 2015-11-16
-$46.43M
derived: sum of 4 quarters · filed 2016-05-10
2015-06-30-$15.01M
10-Q · filed 2015-08-12
-$22.23M
10-Q · filed 2015-08-12
-$32.39M
derived: sum of 3 quarters · filed 2016-05-10
-$46.32M
derived: sum of 4 quarters · filed 2016-05-10
2015-03-31-$7.22M
10-Q · filed 2016-05-10
-$17.38M
derived: sum of 2 quarters · filed 2016-05-10
-$31.31M
derived: sum of 3 quarters · filed 2016-05-10
-$40.25M
derived: sum of 4 quarters · filed 2016-05-10
2014-12-31-$10.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
-$24.08M
derived: sum of 2 quarters · filed 2016-03-29
-$33.03M
derived: sum of 3 quarters · filed 2016-03-29
-$39.26M
10-K · filed 2016-03-29
2014-09-30-$13.93M
10-Q · filed 2015-11-16
-$22.88M
derived: sum of 2 quarters · filed 2015-11-16
-$29.10M
10-Q · filed 2015-11-16
-$38.29M
derived: sum of 4 quarters · filed 2015-11-16
2014-06-30-$8.95M
10-Q · filed 2015-08-12
-$5.41M
10-Q · filed 2014-08-11
-$15.17M
10-Q · filed 2015-08-12
-$8.89M
10-Q · filed 2014-08-11
-$24.36M
derived: sum of 3 quarters · filed 2015-08-12
-$27.39M
derived: sum of 4 quarters · filed 2015-08-12
2014-03-31-$6.22M
10-Q · filed 2015-05-13
-$3.49M
10-Q · filed 2014-05-09
-$15.41M
derived: sum of 2 quarters · filed 2015-05-13
-$18.44M
derived: sum of 3 quarters · filed 2015-05-13
-$28.63M
derived: sum of 4 quarters · filed 2015-05-13
2013-12-31-$9.19M
10-K · filed 2014-03-14
-$12.21M
derived: sum of 2 quarters · filed 2014-11-10
-$22.41M
derived: sum of 3 quarters · filed 2014-11-10
-$14.47M
10-K · filed 2015-03-31
-$37.21M
10-K · filed 2014-03-14
2013-09-30-$3.03M
10-Q · filed 2014-11-10
-$10.20M
10-Q · filed 2013-11-04
-$13.22M
derived: sum of 2 quarters · filed 2014-11-10
-$10.64M
10-Q · filed 2014-11-10
-$28.02M
10-Q · filed 2013-11-04
-$28.75M
derived: sum of 4 quarters · filed 2014-11-10
2013-06-30-$10.19M
10-Q · filed 2014-08-11
-$17.82M
10-Q · filed 2014-08-11
-$25.72M
derived: sum of 3 quarters · filed 2014-08-11
-$37.41M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31-$7.63M
10-Q · filed 2014-05-09
-$15.53M
derived: sum of 2 quarters · filed 2014-03-14
-$27.22M
derived: sum of 3 quarters · filed 2014-03-14
-$37.47M
derived: sum of 4 quarters · filed 2014-03-14
2012-12-31-$7.90M
10-K · filed 2014-03-14
-$19.59M
derived: sum of 2 quarters · filed 2014-03-14
-$29.84M
derived: sum of 3 quarters · filed 2014-03-14
-$42.84M
10-K · filed 2014-03-14
2012-09-30-$11.69M
10-K · filed 2014-03-14
-$21.94M
derived: sum of 2 quarters · filed 2014-03-14
-$34.94M
10-Q · filed 2013-11-04
-$45.57M
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30-$10.25M
10-K · filed 2014-03-14
-$23.25M
10-Q · filed 2013-08-05
-$33.88M
derived: sum of 3 quarters · filed 2014-03-14
-$44.17M
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31-$13.00M
10-K · filed 2014-03-14
-$23.63M
derived: sum of 2 quarters · filed 2014-03-14
-$33.92M
derived: sum of 3 quarters · filed 2014-03-14
-$45.08M
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31-$10.63M
10-K · filed 2013-03-07
-$20.93M
derived: sum of 2 quarters · filed 2013-03-07
-$32.08M
derived: sum of 3 quarters · filed 2013-03-07
-$42.65M
10-K · filed 2014-03-14
2011-09-30-$10.29M
10-K · filed 2013-03-07
-$21.44M
derived: sum of 2 quarters · filed 2013-03-07
-$32.02M
10-Q · filed 2012-11-08
-$44.19M
derived: sum of 4 quarters · filed 2013-03-07
2011-06-30-$11.15M
10-K · filed 2013-03-07
-$21.73M
10-Q · filed 2012-08-07
-$33.90M
derived: sum of 3 quarters · filed 2013-03-07
-$45.31M
derived: sum of 4 quarters · filed 2013-03-07
2011-03-31-$10.57M
10-K · filed 2013-03-07
-$22.75M
derived: sum of 2 quarters · filed 2013-03-07
-$34.16M
derived: sum of 3 quarters · filed 2013-03-07
-$43.10M
derived: sum of 4 quarters · filed 2013-03-07
2010-12-31-$12.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07
-$23.58M
derived: sum of 2 quarters · filed 2013-03-07
-$32.52M
derived: sum of 3 quarters · filed 2013-03-07
-$7.12M
10-K · filed 2013-03-07
2010-09-30-$11.41M
10-Q · filed 2011-11-04
-$20.35M
derived: sum of 2 quarters · filed 2011-11-04
$5.05M
10-Q · filed 2011-11-04
2010-06-30-$8.94M
10-Q · filed 2011-08-04
$16.46M
10-Q · filed 2011-08-04
2009-12-31-$20.61M
10-K · filed 2012-03-09